Somayaji R - Search Results

1

Update on the adverse effects of antimicrobial therapies in community practice.

Mohsen S, Dickinson JA, Somayaji R. Mohsen S, et al. Among authors: somayaji r. Can Fam Physician. 2020 Sep;66(9):651-659. Can Fam Physician. 2020. PMID: 32933978 Free PMC article. Review.

2

Potential implicit bias in attribution of adverse events in randomized controlled trials in cystic fibrosis.

Somayaji R, Wessels ME, Milinic T, Ramos KJ, Mayer-Hamblett N, Ramsey BW, Heltshe S, Khan U, Goss CH. Somayaji R, et al. J Cyst Fibros. 2023 Jul;22(4):669-673. doi: 10.1016/j.jcf.2023.05.014. Epub 2023 Jun 5. J Cyst Fibros. 2023. PMID: 37286384

3

Evaluating the impact of a SIMPlified LaYered consent process on recruitment of potential participants to the Staphylococcus aureus Network Adaptive Platform trial: study protocol for a multicentre pragmatic nested randomised clinical trial (SIMPLY-SNAP trial).

Ong SWX, Lee TC, Fowler RA, Mahar R, Pinto RL, Rishu A, Petrella L, Whiteway L, Cheng M, McDonald E, Johnstone J, Mertz D, Kandel C, Somayaji R, Davis JS, Tong SYC, Daneman N. Ong SWX, et al. Among authors: somayaji r. BMJ Open. 2024 Jan 18;14(1):e083239. doi: 10.1136/bmjopen-2023-083239. BMJ Open. 2024. PMID: 38238170 Free PMC article.

4

Antibiotic Regimen Changes during Cystic Fibrosis Pediatric Pulmonary Exacerbation Treatment.

Cogen JD, Sanders DB, Slaven JE, Faino AV, Somayaji R, Gibson RL, Hoffman LR, Ren CL. Cogen JD, et al. Among authors: somayaji r. Ann Am Thorac Soc. 2023 Sep;20(9):1293-1298. doi: 10.1513/AnnalsATS.202301-078OC. Ann Am Thorac Soc. 2023. PMID: 37327485

5

Mise à jour sur les effets indésirables des traitements antimicrobiens en pratique communautaire.

Mohsen S, Dickinson JA, Somayaji R. Mohsen S, et al. Among authors: somayaji r. Can Fam Physician. 2020 Sep;66(9):e228-e237. Can Fam Physician. 2020. PMID: 32933991 Free PMC article. Review. French.

6

Age and sex-specific incidence rates of group A streptococcal pharyngitis between 2010 and 2018: a population-based study.

Mponponsuo K, Church DL, Lu SJ, Viczko J, Naugler C, McDonald T, Dickinson J, Somayaji R. Mponponsuo K, et al. Among authors: somayaji r. Future Microbiol. 2021 Sep;16:1053-1062. doi: 10.2217/fmb-2021-0077. Epub 2021 Sep 1. Future Microbiol. 2021. PMID: 34468182

7

Antimicrobial Stewardship in Wound Care.

Doyle D, Rennert-May E, Somayaji R. Doyle D, et al. Among authors: somayaji r. Adv Skin Wound Care. 2022 Jul 1;35(7):405-407. doi: 10.1097/01.ASW.0000831884.62594.59. Adv Skin Wound Care. 2022. PMID: 35723959 No abstract available.

8

Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response.

Lam JC, Somayaji R, Surette MG, Rabin HR, Parkins MD. Lam JC, et al. Among authors: somayaji r. BMC Infect Dis. 2015 Mar 22;15:145. doi: 10.1186/s12879-015-0856-5. BMC Infect Dis. 2015. PMID: 25887462 Free PMC article.

9

Clinical implications and characterization of Group A Streptoccoccus infections in adults with cystic fibrosis.

Skolnik K, Nguyen A, Somayaji R, Thornton CS, Waddell B, Surette MG, Rabin HR, Parkins MD. Skolnik K, et al. Among authors: somayaji r. BMC Pulm Med. 2015 Dec 12;15:161. doi: 10.1186/s12890-015-0157-1. BMC Pulm Med. 2015. PMID: 26651825 Free PMC article.

10

The effects of inhaled aztreonam on the cystic fibrosis lung microbiome.

Heirali AA, Workentine ML, Acosta N, Poonja A, Storey DG, Somayaji R, Rabin HR, Whelan FJ, Surette MG, Parkins MD. Heirali AA, et al. Among authors: somayaji r. Microbiome. 2017 May 5;5(1):51. doi: 10.1186/s40168-017-0265-7. Microbiome. 2017. PMID: 28476135 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

142 results

Search Page